Arca biopharma to present at access to giving virtual investor conference on july 13th

Westminster, colo., july 09, 2021 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that thomas keuer, chief operating officer, will present at the access to giving virtual investor conference, which is being held virtually july 13-15, 2021.
ABIO Ratings Summary
ABIO Quant Ranking